1666124-29-3 = 870964-67-3 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Ethanol1.2 Reagents: Citric Acid 标题:Isolation,Synthesis,Identification Of New Process-Related Impurities In Evocalcet 作者:Yan,Hongyi; Et Al 参考文献:Journal Of Pharmaceutical And Biomedical Analysis 日期:2022 卷标:214]
1666124-30-6 = 870964-67-3 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Ethanol,Water; Overnight,Rt1.2 Reagents: Citric Acid Solvents: Chloroform,Water; Ph 7,Cooled1.3 Solvents: Ethanol; 30 Min,50 - 60 °C; 20 Min,Reflux; Reflux -> Rt; Overnight,Rt 标题:Discovery Of Evocalcet,A Next-Generation Calcium-Sensing Receptor Agonist For The Treatment Of Hyperparathyroidism 作者:Miyazaki,Hiroshi; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2018 卷标:28(11) 页码:2055-2060]
1: Akizawa T, Ikejiri K, Kondo Y, Endo Y, Fukagawa M. Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism. Ther Apher Dial. 2019 Sep 5;24(3):248–57. doi: 10.1111/1744-9987.13434. Epub ahead of print. 2: Sakai M, Tokunaga S, Kawai M, Murai M, Kobayashi M, Kitayama T, Saeki S, Kawata T. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism. PLoS One. 2020 Apr 28;15(4):e0232428. doi: 10.1371/journal.pone.0232428. 3: Parfrey PS. Evocalcet in the management of secondary hyperparathyroidism in dialysis patients. Kidney Int. 2018 Oct;94(4):661-662. doi: 10.1016/j.kint.2018.06.022. Evocalcet study group. Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. 2018 Oct;94(4):818-825. doi: 10.1016/j.kint.2018.05.013. Epub 2018 Jul 24. Evocalcet Study Group. Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients. Clin Exp Nephrol. 2019 Feb;23(2):258-267. doi: 10.1007/s10157-018-1635-6. Epub 2018 Aug 29.
合成参考文献
参考文献:10.1016/j.bmcl.2018.04.055 摘要:Miyazaki H, Ikeda Y, Sakurai O, Miyake T, Tsubota R, Okabe J, Kuroda M, Hisada Y, Yanagida T, Yoneda H, Tsukumo Y, Tokunaga S, Kawata T, Ohashi R, Fukuda H, Kojima K, Kannami A, Kifuji T, Sato N, Idei A, Iguchi T, Sakairi T, Moritani Y. Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism. Bioorganic & Medicinal Chemistry Letters. 2018 Jun;28(11):2055–60. doi: 10.1016/j.bmcl.2018.04.055.